Health Adjuvant Nivolumab Promising in Resected Merkel Cell Carcinoma James Pereira Jul 15, 2023 Adjuvant therapy with nivolumab (Opdivo) was… Read More...
Health Adjuvant CRT Yields No Survival Benefit in Advanced Endometrial Cancer James Pereira May 5, 2023 The long-running randomized NRG… Read More...
Health Adjuvant Combo May Change Practice in High-Risk Liver Cancer James Pereira Apr 17, 2023 ORLANDO -- For the first time, adjuvant therapy has… Read More...
Health Updated Results on Adjuvant Immunotherapy in Muscle-Invasive Bladder Cancer James Pereira Mar 7, 2023 In this exclusive roundtable video… Read More...
Health Adjuvant Therapy Recommendations for Breast Cancer Drop Between Ages 69 and 70 James Pereira Feb 4, 2023 Elana Gotkine FRIDAY, Feb. 3, 2023 (HealthDay News) -- Between ages 69 and 70… Read More...
Health FDA OKs Adjuvant Pembrolizumab for NSCLC James Pereira Jan 28, 2023 The FDA has approved… Read More...
Health Adjuvant Chemotherapy Improves Overall Survival for Pancreatic Cancer Patients: Specifically for… James Pereira Dec 9, 2022 Today, the University of Colorado Cancer Center released new research that showcases chemotherapy treatment before and… Read More...
Health Assay Predicts Breast Cancer Patients Who Will Benefit From Ovarian Suppression James Pereira Dec 8, 2022 SAN ANTONIO -- Among premenopausal women with hormone… Read More...
Health Neoadjuvant Anti-PD-1 Strategy Prevails Over Adjuvant in Resectable Melanoma James Pereira Sep 14, 2022 PARIS -- The randomized trial data have spoken, and they… Read More...
Health Three Adjuvant Immunotherapy Trials Flop in Renal Cell Carcinoma James Pereira Sep 13, 2022 PARIS -- While pembrolizumab (Keytruda) has been approved… Read More...